Baijul Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.35 M
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Satisfied Charges ₹ 0.55 M
About Baijul Pharma
Baijul Pharma Pvt Ltd (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 1992 and has a history of 32 years and one month. Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.35 M.
The company currently has active open charges totaling ₹0.50 M. The company has closed loans amounting to ₹0.55 M, as per Ministry of Corporate Affairs (MCA) records.
Hamir Kanani and Chetna Kanani serve as directors at the Company.
Company Details
-
Location
Valsad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1992PTC018670
-
Company No.
018670
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Dec 1992
-
Date of AGM
30 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Baijul Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hamir Kanani
|
Whole-Time Director | 08-Jun-1993 | Current |
|
Chetna Kanani
|
Director | 10-Feb-2021 | Current |
Financial Performance of Baijul Pharma.
Baijul Pharma Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baijul Pharma?
In 2017, Baijul Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.50 M
₹0.55 M
Charges Breakdown by Lending Institutions
- Development Credit Bank Limited : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2011 | Development Credit Bank Limited | ₹0.50 M | Open |
| 14 Oct 1993 | Development Co. Operative Bank Ltd. | ₹0.30 M | Satisfied |
| 20 Sep 1993 | Development Credit Bank Ltd. | ₹0.25 M | Satisfied |
How Many Employees Work at Baijul Pharma?
Unlock and access historical data on people associated with Baijul Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baijul Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baijul Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
